About the Company
We do not have any company description for Tarsus Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TARS News
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: TARS), whose mission is to focus on unmet needs and apply ...
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
Insiders who bought Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) stock lover the last 12 months are probably not ...
OC Drugmakers Cut Headcounts, Close Offices
The Business Journal’s annual listing of the largest local players in the pharmaceutical industry shows a sector that remains ...
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
Investors might want to bet on Tarsus Pharmaceuticals, Inc. (TARS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
9 Best Biotech ETFs for 2024
Biotechnology uses living organisms to develop new medicines and technologies that benefit both environmental and social ...
Global Atherosclerosis Industry is expected to reach US$ 59,514.3 Million, growing at a consistent CAGR of 2.8% | FMI
The Global Atherosclerosis Industry is on track for significant expansion, with a projected Compound Annual Growth Rate (CAGR ...
Pharmaceutical Lactose Market Momentum: Advancing Towards US$ 392.3 Million by 2033, Averaging 5.8% CAGR
According to Future Market Insights’ latest analysis, the global pharmaceutical lactose market size is expected to reach US$ 222.6 million in 2023 and further expand at 5.8% CAGR throughout the ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Addus Homecare (ADUS – Research Report), Pfizer (PFE – ...
Analysts Are Bullish on Top Healthcare Stocks: Thermo Fisher (TMO), Intra-Cellular Therapies (ITCI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Thermo Fisher (TMO – Research Report) and ...
Loading the latest forecasts...